ARTL
NASDAQ · Pharmaceuticals
Artelo Biosciences Inc
$2.12
-0.16 (-6.83%)
Open$2.25
Previous Close$2.27
Day High$2.40
Day Low$2.06
52W High$179.19
52W Low$2.05
Volume—
Avg Volume39.0K
Market Cap1.24M
P/E Ratio—
EPS$-22.97
SectorPharmaceuticals
Analyst Ratings
Strong Sell
6 analysts
Price Target
+642.3% upside
Current
$2.12
$2.12
Target
$15.70
$15.70
$11.87
$15.70 avg
$22.80
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 653.2K | 640.4K | 651.1K |
| Net Income | 176.4K | 175.3K | 172.4K |
| Profit Margin | 27.0% | 27.4% | 26.5% |
| EBITDA | 261.8K | 256.2K | 270.8K |
| Free Cash Flow | 66.8K | 83.8K | 75.0K |
| Rev Growth | -7.3% | -5.3% | +22.2% |
| Debt/Equity | 0.34 | 0.30 | 0.32 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,364.73 | -3.76% | 50.2 | 1.34T |
| JNJ | Johnson & Johnson | $272.32 | -1.45% | 41.3 | 665.03B |
| MRK | Merck & Co. Inc. | $146.94 | -2.27% | 117.2 | 371.99B |
| PFE | Pfizer Inc. | $29.88 | -2.96% | 40.0 | 173.27B |
| BMY | Bristol-Myers Squibb Co | $63.13 | -1.65% | 13.8 | 128.00B |
| ZTS | Zoetis Inc | $82.11 | -7.95% | 12.3 | 32.24B |